Cocaine and cardiovascular complications

American Journal of Therapeutics

Volumn 18, Issue 4, 2011, Pages

  Bhargava, Sandeep ^a   Arora, Rohit R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

aortic dissection; beta blockers; cardiomyopathy; chest pain; cocaine; hypertension

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CATECHOLAMINE; CLOXACILLIN; COCAINE; CONTRAST MEDIUM; CREATINE KINASE; DEXMEDETOMIDINE; DOPAMINE; GLYCERYL TRINITRATE; LABETALOL; NAFCILLIN; NITROPRUSSIDE SODIUM; NORADRENALIN; OXACILLIN; PHENTOLAMINE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; SEDATIVE AGENT; TROPONIN C; VASODILATOR AGENT; VERAPAMIL;

ACUTE HEART INFARCTION; ADRENERGIC TRANSMISSION; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; AORTA DISSECTION; AORTA SURGERY; BACTERIAL ENDOCARDITIS; BLOOD PRESSURE REGULATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COCAINE DEPENDENCE; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DOPAMINE UPTAKE; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; ELECTROCARDIOGRAPHY; ENDOCARDITIS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INCIDENCE; MEMBRANE PERMEABILITY; NORADRENALIN UPTAKE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS INFECTION; THORAX PAIN; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COCAINE; COCAINE-RELATED DISORDERS; HUMANS;

EID: 79960559622     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181ea30eb     Document Type: Review

References (61)

1. Substance Abuse and Mental Health Services Adminis-tration, Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: detailed tables. Available at: http://www.oas.samhsa.gov/nsduhLatest. htm. Accessed October 1, 2009.
2. Substance Abuse and Mental health Services Administra-tion, Office of Applied Studies. DAWN Series D-30, DHHS Publication No. (SMA) 08-4339. Rockville, MD; 2008. Available at: http://dawninfo.samhsa.gov/files/ED2006/ DAWN2k6ED.htm. Accessed October 1, 2009.
3. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100:1040.
4. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl JMed. 2001;345:351.
5. Grant T, Brown Z, Callahan C, et al. Cocaine exposure during pregnancy: improving assessment with radioim-munoassay of maternal hair. Obstet Gynecol. 1994;83: 524-531.
6. Kline J, Ng SKC, Schittini M, et al. Cocaine use during pregnancy: sensitive detection by hair assay Am J Public Health. 1997;87:352-358. (Pubitemid 27157445)
7. Garcia-Bournissen F, Moller M, Nesterenko M, et al. Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use. Forensic Sci Int. 2009; 189:24-27.
8. Vongpatanasin W, Mansour Y, Chavoshan B, et al. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100: 497-502. (Pubitemid 29360158)
9. Sharkey J, Ritz MC, Schenden JA, et al. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther. 1988;246:1048-1052.
10. Newlin DB. Effect of cocaine on vagal tone: a common factors approach. Drug Alcohol Depend. 1995;37:211-216.
11. Rump AF, Theisohn M, Klaus W. The pathophysiology of cocaine cardiotoxicity. Forensic Sci Int. 1995;71:103-115.
12. Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther. 2003;97: 181-222. (Pubitemid 36165169)
13. Devi BG, Chan AW. Effect of cocaine on cardiac bio-chemical functions. J Cardiovasc Pharmacol. 1999; 33:1-6. (Pubitemid 29013693)
14. Fineschi V, Baroldi G, Centini F, et al. Markers of cardiac oxidative stress and altered morphology after intraper-itoneal cocaine injection in a rat model. Int J Legal Med. 2001;114:323-330. (Pubitemid 32691854)
15. Moritz F, Monteil C, Isabelle M, et al. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc Res. 2003;59:834-843. (Pubitemid 38366239)
16. Isabelle M, Monteil C, Moritz F, et al. Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction. Cardiovasc Res. 2005;67:699-704. (Pubitemid 41033365)
17. Behonick GS, Novak MJ, Nealley EW, et al. Toxicology update: the cardiotoxicity of the oxidative stress metab-olites of catecholamines (aminochromes). J Appl Toxicol. 2001;21(Suppl 1):S15-S22.
18. Remondino A, Kwon SH, Communal C, et al. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway Circ Res. 2003;92:136-138. (Pubitemid 36254269)
19. Amin JK, Xiao L, Pimental DR, et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol. 2001;33:131-139. (Pubitemid 32127790)
20. Bleeke T, Zhang H, Madamanchi N, et al. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res. 2004;94:37-45. (Pubitemid 38064096)
21. Isabelle M, Vergeade A, Moritz F, et al. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol. 2007;42:326-32. (Pubitemid 46156951)
22. Muscholl E. Effects of cocaine and related drugs on the uptake of noreadrenaline by heart and spleen. Br J Pharmacol. 1961;16:352-359.
23. Furchgott RF, Kirpeker SM, Rieker M, et al. Action and interactions of norepinephrine, tyramine, and cocaine on aortic strips of rabbit and left atria guinea pig and cat. J Pharmacol. 1963;142:39-58.
24. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, et al, eds. The Pharmacologic Basis of Therapeutics. New York: Pergoman Press; 1990:539-546.
25. Su J, Li J, Li W, et al. Cocaine induces apoptosis in primary cultured rat aortic vascular smooth muscle cells: possible relationship to aortic dissection, atherosclerosis, and hypertension. Int J Toxicol. 2004;23:233-237. (Pubitemid 39346622)
26. Tuncel M, Wang Z, Arbique D, et al. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation. 2002;105:1054-1059. (Pubitemid 34212613)
27. Sofuoglu M, Nelson D, Babb DA, et al. Intravenous cocaine increases plasma epinephrine and norepineph-rine in humans. Pharmacol Biochem Behav. 2001;68:455-459. (Pubitemid 32452401)
28. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94:608-610. (Pubitemid 23166707)
29. Negus BH, Willard JE, Hillis LD, et al. Alleviation of cocaine-induced coronary vasoconstriction with intrave-nous verapamil. Am J Cardiol. 1994;73:510-513. (Pubitemid 24096216)
30. Menon DV, Wang Z, Fadel PJ, et al. Central sympatholysis as a novel countermeasure for cocaine-induced sympa-thetic activation and vasoconstriction in humans. J Am Coll Cardiol. 2007;50:626-633. (Pubitemid 47199006)
31. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med. 1994;1:330-339.
32. Feldman JA, Fish SS, Beshansky JR, et al. Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med. 2000;36: 469-476.
33. Hollander JE, Lozano M, Fairweather P, et al. Abnormal electrocardiograms in patients with cocaine-associated chest pain are due to normal variants. J Emerg Med. 1994; 12:199-205.
34. Flores ED, Lange RA, Cigarroa RG, et al. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol. 1990;16:74-79. (Pubitemid 20217044)
35. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Associ-ation Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897-1907. (Pubitemid 351507480)
36. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325-331. (Pubitemid 20147265)
37. Hollander JE, Hoffman RS, Burstein JL, et al. Cocaine-associated myocardial infarction. Mortality and compli-cations. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med. 1995;155:1081-1086.
38. Mittleman MA, Mintzer D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation. 1999;99: 2737-2741. (Pubitemid 29250018)
39. Hollander JE, Levitt MA, Young GP, et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis ofacute myocardial infarction. Am Heart J. 1998; 135:245-252. (Pubitemid 28139164)
40. Amin M, Gabelman G, Karpel J, et al. Acute myocardial infarction and chest pain syndromes after cocaine use. Am J Cardiol. 1990;66:1434-1437.
41. Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med. 1992;10:169-177
42. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guide-lines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: part 6: advanced cardio-vascular life support: section 1: introduction to ACLS 2000: overview of recommended changes in ACLS from the Guidelines 2000 Conference. Circulation. 2000;102(Suppl I): I-86-I-89.
43. Albertson TE, Dawson A, de Latorre F, et al; American Heart Association; International Liaison Committee on Resuscitation. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med. 2001;37:S78-S90. (Pubitemid 32332131)
44. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction\- executive summary J Am Coll Cardiol. 2007;50:652-726.
45. Page RL 2nd, Utz KJ, Wolfel EE. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome? Ann Pharmacother. 2007;41:2008-2013. (Pubitemid 350230569)
46. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897-903. (Pubitemid 20193673)
47. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267-1272.
48. Yung D, Kottachchi D, Neupane B, et al. Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review.JAntimicrob Chemother. 2007;60:921-928. (Pubitemid 47617736)
49. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000;30:374-379. (Pubitemid 30131549)
50. Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am. 2002;16:273-295. (Pubitemid 34663637)
51. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017-1028. (Pubitemid 23334659)
52. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
53. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis. Diagnosis, antimicrobial therapy, and man-agement of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardio-vascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association\-executive summary: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:3167-3184.
54. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation. 2002;105: 1592-1595. (Pubitemid 34297638)
55. Nallamothu BK, Saint S, Kolias TJ, et al. Of nicks and time. N Engl J Med. 2001;345:359-363. (Pubitemid 32703240)
56. Kloner RA, Hale S, Alker K, et al. The effects of acute and chronic cocaine use on the heart. Circulation. 1992;85: 407-419.
57. Kolodgie FD, Virmani R, Cornhill JF, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17:1553-1560.
58. Singh S, Trivedi A, Adhikari T, et al. Cocaine-related acute aortic dissection: patient demographics and clinical outcomes. Can J Cardiol. 2007;23:1131-1134. (Pubitemid 351255687)
59. Restrepo CS, Rojas CA, Martinez S, et al. Cardiovascular complications of cocaine: imaging findings. Emerg Radiol. 2009;16:11-19.
60. Eagle KA, Isselbacher EM, DeSanctis RW; International Registry for Aortic Dissection (IRAD) Investigators. Cocaine-related aortic dissection in perspective. Circula-tion. 2002;105:1529-1530. (Pubitemid 34297624)
61. Daniel JC, Huynh TT, Zhou W, et al. Acute aortic dissection associated with use of cocaine. J Vasc Surg. 2007;46:427-433. (Pubitemid 47371065)